| Financial Year |
March 31 2023 |
| Monetary Funds |
75,447,385.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
36,983,045.33 |
| Advances to Suppliers |
7,033,132.80 |
| Other Receivables |
374,465,742.59 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
15,282,652.43 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
117,890.98 |
| Total Current Assets |
509,329,849.29 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
225,339,440.97 |
| Investment Properties |
-- |
| Fixed Assetes |
75,472,147.31 |
| Under-construction Projects |
17,199,211.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
4,550,640.94 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
120,000.00 |
| Deferred Income Tax Assets |
10,580,498.15 |
| Other Non-Current Assets |
25,534,000.00 |
| Sub-Total of Non-Current Assets |
358,795,938.75 |
| Total Assets |
868,125,788.04 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
12,994,459.75 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,463,784.63 |
| Taxes Payable |
10,085,394.76 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
501,598,856.53 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
526,142,495.67 |
| Long-term Loans |
4,300,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
40,966,121.72 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
46,055,163.13 |
| Total Liabilities |
572,197,658.80 |
| Paid-In Capital(Or Share Stock) |
263,758,491.00 |
| Capital Surplus |
24,059,607.52 |
| Surplus Reserve |
69,225,086.27 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-394,652,607.84 |
| Minority Stockholder's Interest |
333,537,552.29 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
-37,609,423.05 |
| Owner's Equity（Stockholder's Equity） |
295,928,129.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
868,125,788.04 |
